Quality of life measurement in the second Australian National Blood Pressure Study (ANBPS2)

Simple item page
dc.contributor.authorMoss, J.
dc.contributor.authorMarley, J.
dc.contributor.authorWing, L.
dc.date.issued1995
dc.descriptionSee pg.12 of pdf Abstract from: 11th International Conference on Pharmacoepidemiology, Montréal, Canada, 27–30 August 1995 Article first published online: 31 JAN 2006
dc.description.statementofresponsibilityJohn R. Moss, John Marley, Lindon Wing and High Blood Pressure Research Council of Australia
dc.identifier.citationPharmacoepidemiology and Drug Safety, 1995; 4(Suppl.1):12-
dc.identifier.doi10.1002/pds.2630040702
dc.identifier.issn1053-8569
dc.identifier.issn1099-1557
dc.identifier.orcidMoss, J. [0000-0003-4216-1761]
dc.identifier.urihttp://hdl.handle.net/2440/6245
dc.language.isoen
dc.publisherJohn Wiley & Sons
dc.rights© 1995 John Wiley & Sons, Ltd
dc.source.urihttps://doi.org/10.1002/pds.2630040702
dc.subjecthypertension
dc.subjecteconomics
dc.subjectoutcome study
dc.subjectdiuretic
dc.subjectACE inhibitor
dc.titleQuality of life measurement in the second Australian National Blood Pressure Study (ANBPS2)
dc.typeJournal article
pubs.publication-statusPublished

Files

Collections

General Practice publications